Legal & General Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-18,436
| Closed | -$24K | – | 3723 |
|
|
2022
Q1 | $24K | Sell |
18,436
-333,511
| -95% | -$307K | ﹤0.01% | 3199 |
|
|
2021
Q4 | $445K | Sell |
351,947
-24,736
| -7% | -$44.2K | ﹤0.01% | 2453 |
|
|
2021
Q3 | $821K | Buy |
376,683
+37,031
| +11% | +$101K | ﹤0.01% | 2293 |
|
|
2021
Q2 | $1.27M | Sell |
339,652
-61,606
| -15% | -$214K | ﹤0.01% | 2144 |
|
|
2021
Q1 | $1.31M | Sell |
401,258
-1,641
| -0.4% | -$5.88K | ﹤0.01% | 2125 |
|
|
2020
Q4 | $1.38M | Buy |
402,899
+3,398
| +0.9% | +$14K | ﹤0.01% | 2027 |
|
|
2020
Q3 | $1.63M | Buy |
399,501
+83,634
| +26% | +$318K | ﹤0.01% | 1855 |
|
|
2020
Q2 | $1.07M | Buy |
315,867
+25,429
| +9% | +$74.1K | ﹤0.01% | 1963 |
|
|
2020
Q1 | $677K | Sell |
290,438
-47,572
| -14% | -$130K | ﹤0.01% | 1978 |
|
|
2019
Q4 | $1.23M | Buy |
338,010
+41,143
| +14% | +$332K | ﹤0.01% | 1995 |
|
|
2019
Q3 | $2.46M | Sell |
296,867
-5,795
| -2% | -$46.9K | ﹤0.01% | 1630 |
|
|
2019
Q2 | $2.61M | Buy |
302,662
+4,852
| +2% | +$43.4K | ﹤0.01% | 1581 |
|
|
2019
Q1 | $3.18M | Buy |
297,810
+42,066
| +16% | +$450K | ﹤0.01% | 1463 |
|
|
2018
Q4 | $2.25M | Buy |
255,744
+16,608
| +7% | +$212K | ﹤0.01% | 1527 |
|
|
2018
Q3 | $4M | Buy |
239,136
+30,667
| +15% | +$664K | ﹤0.01% | 1318 |
|
|
2018
Q2 | $4.38M | Buy |
208,469
+17,972
| +9% | +$333K | ﹤0.01% | 1195 |
|
|
2018
Q1 | $3.08M | Buy |
190,497
+26,687
| +16% | +$529K | ﹤0.01% | 1373 |
|
|
2017
Q4 | $3.1M | Buy |
163,810
+24,859
| +18% | +$450K | ﹤0.01% | 1371 |
|
|
2017
Q3 | $1.95M | Buy |
138,951
+7,212
| +5% | +$65.2K | ﹤0.01% | 1601 |
|
|
2017
Q2 | $981K | Buy |
131,739
+10,922
| +9% | +$71.4K | ﹤0.01% | 1836 |
|
|
2017
Q1 | $785K | Buy |
120,817
+3,627
| +3% | +$20.3K | ﹤0.01% | 1886 |
|
|
2016
Q4 | $519K | Buy |
117,190
+56,397
| +93% | +$237K | ﹤0.01% | 1970 |
|
|
2016
Q3 | $282K | Buy |
60,793
+47,806
| +368% | +$283K | ﹤0.01% | 1943 |
|
|
2016
Q2 | $85K | Hold |
12,987
| – | – | ﹤0.01% | 2189 |
|
|
2016
Q1 | $81K | Buy |
12,987
+3,307
| +34% | +$17K | ﹤0.01% | 2183 |
|
|
2015
Q4 | $59K | Hold |
9,680
| – | – | ﹤0.01% | 2373 |
|
|
2015
Q3 | $58K | Hold |
9,680
| – | – | ﹤0.01% | 2372 |
|
|
2015
Q2 | $64K | Hold |
9,680
| – | – | ﹤0.01% | 2422 |
|
|
2015
Q1 | $59K | Hold |
9,680
| – | – | ﹤0.01% | 2411 |
|
|
2014
Q4 | $68K | Hold |
9,680
| – | – | ﹤0.01% | 2259 |
|
|
2014
Q3 | $80K | Buy |
+9,680
| New | +$75.7K | ﹤0.01% | 2060 |
|
Other funds holding SPPI
ACM
E
Legal & General Group's SPPI Position: Q2 2022 in Review
Legal & General Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2022, closing a stake of 18,436 shares — an estimated $24K sold.
Legal & General Group first reported a position in SPPI in Q3 2014 and held it in 31 quarters. The position peaked at $4.38M in Q2 2018. 86 funds tracked by Wall St. Rank hold SPPI as of Q2 2022.
- Legal & General Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2022 after selling out during the quarter.
- Legal & General Group sold 18,436 Spectrum Pharmaceuticals Inc shares in Q2 2022, an estimated $24K.
- Legal & General Group first reported a position in Spectrum Pharmaceuticals Inc in Q3 2014 and held it in 31 quarters.
- Legal & General Group's Spectrum Pharmaceuticals Inc position peaked at $4.38M in Q2 2018.
- 86 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2022.
Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.